BIO.PA: Headlines for BIOALLIANCE PHARMA - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 2:12am EST - Canadian Markets open in 7 hours and 18 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

BIOALLIANCE PHARMA (BIO.PA)

On Feb 9: 4.65 EUR

0.02 (0.43%)

MORE ON BIO.PA

Quotes

Charts

News & Info

Headlines

Company

Analyst Coverage

Ownership

Financials

Headlines	Get Headlines for:

Tue, Feb 9, 2010
•	BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues Business Wire (Tue 12:30pm)
•	BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues Business Wire (Tue 12:30pm)
Tue, Dec 15, 2009
•	BioAlliance Pharma : Entry into Clinical Phase: Clonidine Lauriad® into Phase II and AMEPTM into Phase I Business Wire (Tue, Dec 15)
•	BioAlliance Pharma : Entry into Clinical Phase: Clonidine Lauriad® into Phase II and AMEPTM into Phase I Business Wire (Tue, Dec 15)
Thu, Dec 10, 2009
•	BioAlliance Pharma: Breakthrough positive phase III results with acyclovir Lauriad® Primary and secondary endpoints met Final results Business Wire (Thu, Dec 10)
•	BioAlliance Pharma: Breakthrough positive phase III results with acyclovir Lauriad® Primary and secondary endpoints met - Final results Business Wire (Thu, Dec 10)
Tue, Dec 8, 2009
•	Doxorubicin Transdrug®: Significant increased survival rate in patients with advanced hepatocellular carcinoma treated in a phase II clinical trial Business Wire (Tue, Dec 8)
•	Doxorubicin Transdrug®: Significant increased survival rate in patients with advanced hepatocellular carcinoma treated in a phase II clinical trial Business Wire (Tue, Dec 8)
Mon, Nov 23, 2009
•	BioAlliance Pharma Presents Efficacy and Safety Preclinical Results for Its AMEP Anti-Invasive Biotherapy at The ESGCT Annual Congress in Hannover, No Business Wire (Mon, Nov 23)
•	BioAlliance Pharma Presents Efficacy and Safety Preclinical Results for Its AMEP Anti-Invasive Biotherapy at The ESGCT Annual Congress in Hannover, November 21 to 25, 2009 Business Wire (Mon, Nov 23)
Thu, Nov 19, 2009
•	BioAlliance Pharma ranked as France's fastest growing company in the 2009 Deloitte Technology Fast 50 Business Wire (Thu, Nov 19)
•	BioAlliance Pharma ranked as France's fastest growing company in the 2009 Deloitte Technology Fast 50 Business Wire (Thu, Nov 19)
Thu, Nov 12, 2009
•	BioAlliance Pharma Presents Results for Its New Oral Chemotherapy Nanoparticle Innovation at the AAPS Annual Meeting in Los Angeles, November 8 to 12, Business Wire (Thu, Nov 12)
•	BioAlliance Pharma Presents Results for Its New Oral Chemotherapy Nanoparticle Innovation at the AAPS Annual Meeting in Los Angeles, November 8 to 12, 2009 Business Wire (Thu, Nov 12)
Older Headlines
View headlines from:

Add to Portfolio

Email to a Friend

•